

314
Cuando IP es activado por PGI
2
, estimula a adeni-
lato ciclasa (AC), cuya isoforma más importante
a nivel pulmonar es la AC
2
, incrementando los
niveles intracelulares de adenosina-monofosfato
cíclico (AMPc). Los niveles incrementados de
AMPc conllevan a la activación de la proteína
quinasa A (PKA) y posterior fosforilación de
proteínas claves. Los efectos de la PGI
2
en las
células vasculares están mediados por diferentes
vías de señalización, incluyendo la vía PGI
2
/IP/
Gs/AMPc clásico y las vías intracrinas que impli-
can receptores nucleares
34
.
Agradecimientos
Los autores agradecen el apoyo financiero a
sus investigaciones otorgado por los proyectos
FONDECyT 114064, 1151119 y VID Enlace
Universidad de Chile
.
Bibliografía
1.- Rudolph A. Fetal and Neonatal Pulmonary Circula-
tion Ann. Rev. Physiol. 1979; 41: 383-95.
2.- Abman SH. Recent advances in the pathogenesis and
treatment of persistent pulmonary hypertension of the
newborn. Neonatology 2007; 91: 283-90.
3.- Gao Y, Raj U. Regulation of the pulmonary circula-
tion in the fetus and the newborn. Physiol Rev. 2010;
90: 12191-1335.
4.- Hillman N, Kallapur SG, Jobe A. Physiology
of transition from intrauterine to extrauterine life. Clin
Perinatol. 2012; 39: 769-83.
5.- Hooper SB, Te Pas AB, Lang J, Van Vonde-
ren JJ, Roehr CC, Kluckow M, et al. Cardio-
vascular transition at birth: a physiological sequence.
Pediatric Research. 2015; 77: 608-14.
6.- Haworth SG. Development of the normal and
hypertensive pulmonary vasculature. Experimental
physiology 1995; 80: 843-53.
7.- Haworth SG, Hall SM, Chew M, Allen K.
Thinning of fetal pulmonary arterial wall and postnatal
remodeling: ultrastructural studies on the respiratory
unit arteries of the pig. Virchows Arch A Pathol Anat
Histopathol. 1987; 411: 161-71.
8.- Peñaloza D, Arias-Stella J. The heart and
pulmonary circulation at high altitudes: healthy highlan-
ders and chronic Mountain sickness. Circulation 2007;
115: 1132-46.
9.- Murthy KS. Signaling for contraction and relaxation
in smooth muscle of the gut. Ann Rev Physiol. 2006;
68: 345-74.
10.- Ogut O, Brozovich F. The potential role of MLC
phosphatase and MAPK signalling in the pathogenesis
of vascular dysfunction in heart failure. J Cell Mol Med.
2008; 12: 2158-64.
11.- Wray S , Burdyga T. Sarcoplasmic reticulum
function in smooth muscle. Physiological reviews.
2010; 90: 113-78.
12.- Yang XR, Lin MJ, Sham JS. Physiological
functions of transient receptor potential channels in
pulmonary arterial smooth muscle cells. In: Membrane
Receptors, Channels and Transporters in Pulmonary Cir-
culation.Springer International Publishing AG. Humana
Press. New York. 2010; pp 109-22.
13.- Jernigan NL, Resta TC. Calcium homeostasis
and sensitization in pulmonary arterial smooth muscle.
Microcirculation. 2014; 21: 259-71.
14.- Butler T, Paul J, Europe-Finner N, Smith
R, Chan EC. “Role of serine-threonine phosphopro-
tein phosphatases in smooth muscle contractility”. Am
J Physiol - Cell Physiol 2013; 304: C485-504.
15.- Xiong Z, Sperelakis N. Regulation of L-type
calcium channels of vascular smooth muscle cells. J
Molecular cellular cardiol. 1995; 27: 75-91.
16.- Raeymaekers L, Hofmann F, Casteels R.
Cyclic GMP-dependent protein kinase phosphorylates
phospholamban in isolated sarcoplasmic reticulum from
cardiac and smooth muscle. Biochem J. 1988; 252269-
73.
17.- Sylvester JT, Shimoda LA, Aaronson PI,
Ward JPT. Hypoxic pulmonary vasoconstriction.
Physiol Rev 2012; 92: 367-520.
18.- Khapchaev AY, Shirinsky P. Myosin light
chain kinase MYLK1: anatomy, interactions, functions,
and regulation. Biochemistry (Moscow); 2016; 81:
1676-97.
19.- Wilson DP, Susnjar M, Kiss E, Suther-
land C, Walsh MP. Thromboxane A2-induced
contraction of rat caudal arterial smooth muscle in-
volves activation of Ca
2+
entry and Ca
2+
sensitization:
Rho-associated kinase-mediated phosphorylation of
MYPT1 at Thr-855, but not Thr-697. Biochem J. 2005;
389: 763-74.
20.- Kawka DW, Ouellet M, Hétu P, Singer
II, Riendeau D. Double-label expression studies
of prostacyclin synthase, thromboxane synthase and
COX isoforms in normal aortic endothelium. Biochim
Biophys Acta 2007; 1771: 45-54.
21.- Delaney C, Gien J, Grover TR, Roe G,
Abman SH. Pulmonary vascular effects of serotonin
and selective serotonin reuptake inhibitors in the late-
gestation ovine fetus. American J Physiol-Lung Cellular
Molecular Physiol. 2011, 301: L937-L944.
22.- Kloza M, Baranowska-Kuczko M,
Pedinska-Betiuk A, Jackowski K, Kos-
lowska H. Serotonin hypothesis and pulmonary
artery hypertension. Postepy Hig Med Dows. 2014; 68:
738-48.
23.- Webb RC. Smooth muscle contraction and relaxation.
Advn Physiol education. 2003; 27: 201-16.
Rev Chil Enferm Respir 2017; 33: 308-315
F. A. Beñaldo F. et al.